Aptus Capital Advisors »

Ocular Therapeutix shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 263k 8.70
2024-06-30 $1.8M 263k 6.84

More positions owned by Aptus Capital Advisors

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Broadcom (AVGO)
Apple (AAPL)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Etf Ser Solutions Aptus Enhanced (JUCY)
Ishares Tr Core Msci Intl (IDEV)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Etf Ser Solutions Aptus Large Cap (DUBS)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Etf Ser Solutions Aptus Drawdown (ADME)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Aptus Capital Advisors

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
BlackRock
Vanguard Group
TCG Crossover Management
Logos Global Management
Opaleye Management
Citadel Advisors
State Street Corporation
Perceptive Advisors
Geode Capital Management
Assenagon Asset Management
Deltec Asset Management

View all funds holding Ocular Therapeutix